INTS vs MSCI · $7.7M cap vs P/E 37, rev $2.86B
Intensity Therapeutics, Inc. Common stock (INTS) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported MSCI revenue for 2024-12-31 was $2.86B. Net income was $1.11B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
INTS currently screens at market cap $7.7M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the INTS and MSCI stock pages for the full models.
Not investment advice.